Enfortumab vedotin | Interleukin Related interleukin-related.com

Product Name :
Enfortumab vedotin

Search keywords :
Val-Cit

drugId :
null

Target Vo:
Nectin-4

Target Vo Short Name :
NECTIN4

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :
United States

First Approval Date Filter:
2019

Origin Company_Name :
Agensys Inc

Active Company_Name :
Astellas (China) Investment Co Ltd

Active Indication_Name:
Carcinoma, Transitional Cell

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Cyclin B1 (Ser126) Rabbit mAb Biological Activity
delta Tubulin Antibody In Vitro
Adipose Triglyceride Lipase Antibody: Adipose Triglyceride Lipase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Adipose Triglyceride Lipase. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts